Skip to main content
OpenTrials
Completed

NCT Number: NCT03898063

90 DAYS: An Entertainment Education Intervention to Evaluate a Short Film About HIV Status Disclosure

This investigation seeks to understand if and how, the 90 Days film can be used as an intervention to address HIV-related stigmas, intimate partner status disclosure and HIV ART medical adherence among Black HIV positive women.

Completed

Looking for future studies?

Notify Me

Key information

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Black women ages 18-50
  • clinically diagnosed with HIV/AIDS
  • Speak and comprehend English

Exclusion criteria

  • pregnant women

Treatment and study plan

90 DAYS film

Behavioral

the intervention conditions include exposure to a film, 90 DAYS (approx 20 minutes long), an entertainment film detailing a woman's decision to tell her romantic partner that she is HIV-positive.

HIV pamphlet on disclosure

Behavioral

A standard-of-care brochure given to newly diagnosed HIV patients about the importance of status disclosure

Primary outcomes

  1. HIV Self-stigmatization as Assessed Via Self Stigmatization Questionnaire

    Time frame: Day 1 post test

    self-report measure of the extent to which participants stigmatize themselves for being HIV positive. Quantified in the manuscript using the mean of the self-report scale. Scores range from 1-5 with higher scores indicating higher perceptions of self-stigmatization.

  2. HIV Disclosure Intentions as Assessed by Disclosure Intentions Scale

    Time frame: Day 1 post-test

    Self-report measure of the extent to which participants intend to disclose their HIV status to a partner. Quantified in the manuscript using the mean of the self-report scale. Scores range from 1-5 with higher scores indicating higher intentions of status disclosure.

  3. Medical Adherence Intentions as Measured by the Medical Adherence Scale

    Time frame: Day 1 post-test

    Self-report measure of participants likeliness to miss doses of their antiretroviral medication over a 30 day period. Quantified in the manuscript using the mean of the self-report scale. Scores range from 1-5 with higher scores indicating increased likeliness to miss doses of antiretroviral medication.

Sponsors and collaborators

Lead sponsor

University of Miami

Other

Registry information

Official study title

An Experimental Investigation of the Effects of an Entertainment Education Short Film on Internalized HIV-related Stigma, Sexual Partner Status Disclosure, and Medical Adherence Intentions Among Black HIV-positive Women in Miami-Dade County

Important dates

Study start
2019
Primary completion
2020
Study completion
2020
First posted
Apr 1, 2019
Registry last updated
Jul 2, 2021

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.